EWG Elevate’s Arcadia Biosciences RKDA Stock Holding History

EWG Elevate’s Portfolio RKDA Stock Details RKDA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-13	Closed	-$3K	–	77
2019 Q4	$3K	Buy	+13	New	+$2.61K	﹤0.01%	73

Other funds holding RKDA

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Clearstead Advisors Cleveland, Ohio $10.9B AUM 18.41% 1-Year Est. Return

EWG Elevate's RKDA Position: Q1 2020 in Review

EWG Elevate sold out of Arcadia Biosciences (RKDA) in Q1 2020, closing a stake of 13 shares — an estimated $3K sold.

EWG Elevate first reported a position in RKDA in Q4 2019 and held it in 1 quarter. The position peaked at $3K in Q4 2019. 12 funds tracked by Wall St. Rank hold RKDA as of Q1 2020.

EWG Elevate reported no remaining Arcadia Biosciences position as of Q1 2020 after selling out during the quarter.
EWG Elevate sold 13 Arcadia Biosciences shares in Q1 2020, an estimated $3K.
EWG Elevate first reported a position in Arcadia Biosciences in Q4 2019 and held it in 1 quarter.
EWG Elevate's Arcadia Biosciences position peaked at $3K in Q4 2019.
12 funds tracked by Wall St. Rank held Arcadia Biosciences as of Q1 2020.

Based on EWG Elevate's 13F filing for Q1 2020, filed 15 Apr 2020.